Academic publishing in Europe and N. America

Archive Publication ethics Submission Payment Contacts
In the original languageTranslation into English

Molecular genetic features of vulva squamous cell carcinoma depending on HPV status

Authors

Polatova Djamila, Navruzova Visola

Rubric:Medicine
393
0
Download articleQuote
393
0

Annotation

The study included materials from 76 operations (110 paraffin blocks), which did not undergo neoadjuvant treatment methods, since preoperative exposure to tumors could significantly affect the results of the study, which is why these samples were not included in the study. It was found that a high viral load of HPV in VC correlates with the presence of metastases in the lymph nodes, invasion of the stroma, the degree of differentiation, and lymphovascular invasion, while it is not associated with the stage of the disease. Expression of PD-L1 receptors was more frequently observed in HPV negative VC patients compared to HPV positive ones (7.8 vs 3.7 p=0.03), while STK11 mutation was more common in HPV positive patients. At the same time, the PIK3CA E545 mutation occurred with the same frequency between the two groups of VC patients

Keywords

mutation
signaling pathway
epigene
apoptosis receptor
cell cycle
transcription

Authors

Polatova Djamila, Navruzova Visola

References:

  1. Allen DG, Hutchins AM, Hammet F, White DJ, Scurry JP, Tabrizi SN, et al. Genetic aberrations detected by comparative genomic hybridisation in vulvar cancers. Br J Cancer 2002;86:924–8.
  2. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611–22.
  3. Hampl  M,  Sarajuuri  H,  Wentzensen  N,  Bender  HG,  Kueppers  V. Effect  of  human  papillomavirus  vaccines  on  vulvar,  vaginal,  and anal  intraepithelial  lesions  and  vulvar  cancer.  Obstet Gynecol. 2006;108:1361–1368.
  4. Hansen  BT,  Campbell  S,  Nygard  M.  Long- term  incidence  trends  of HPV- related  cancers,  and  cases  preventable  by  HPV vaccination: A registry- based study in Norway. BMJ Open. 2018;8:e019005.
  5. Lavorato-Rocha AM, Anjos LG, Cunha IW, Vassallo J, Soares FA, Rocha RM. Immunohistochemical assessment of PTEN in vulvar cancer: best practices for tissue staining, evaluation, and clinical association. Methods 2015;77– 8:20–4.
  6. Lavorato-Rocha AM, de Melo Maia B, Rodrigues IS, Stiepcich MM, Baiocchi, da Silva Cestari FM, et al. Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein. Ann Surg Oncol 2013;20:31–9.
  7. Lavorato-Rocha AM, Rodrigues IS, de Melo Maia B, Stiepcich MM, Baiocchi G, Carvalho KC, et al. Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma. Tumour Biol 2013;34:3713–20.

Other articles of the issue

Majid Ismaeel Abdalrazzaq, Ali Adel Hamza Using of evaporative condensers for combined power plant
Download article in PDF3-9 pages472 views
cc-license
About us Journals Books
Publication ethics Terms of use of services Privacy policy
Copyright 2013-2024 Premier Publishing s.r.o.
Praha 8 - Karlín, Lyčkovo nám. 508/7, PSČ 18600, Czech Republic pub@ppublishing.org